Polymyositis

Top Story

Patients with dermatomyositis, anti-NXP-2 antibodies have severe phenotype

February 13, 2017

Patients with dermatomyositis and anti-NXP-2 antibodies had a severe systemic phenotype, which included myalgia, peripheral edema and significant dysphagia, according to recently published data.

“Like most rheumatic diseases, dermatomyositis (DM) can have a wide range of target organ manifestations,” David Fiorentino, MD, PhD, in the Department of Dermatology at the Stanford University School of Medicine, and colleagues wrote. “This heterogeneity of manifestations presents both challenge and opportunity — there is challenge in rendering the correct diagnosis but opportunity to assess if clinical nuance may have pathologic or prognostic significance.”

In the Journals

Baseline shoulder ultrasonography did not predict glucocorticoid response in patients with polymyalgia

February 2, 2017
Baseline shoulder ultrasonography was not predictive of glucocorticoid response in patients with polymyalgia rheumatica after 12 months, according to results of a…
In the Journals

Population-based study: Low annual incidence of mixed connective tissue disease

December 8, 2016
Based on a cohort in Minnesota from 1985 through 2014, researchers found the yearly occurrence of mixed connective tissue disease to be two people per 100,000. Using…
In the Journals

New questionnaire more accurately identified rheumatic disease

November 8, 2016
Researchers from the University of Toronto developed a new questionnaire to more accurately screen for rheumatic disease in the outpatient setting. Susan M. Armstrong
In the Journals

Patients with dermatomyositis, anti-NXP-2 antibodies have severe phenotype

February 13, 2017
Patients with dermatomyositis and anti-NXP-2 antibodies had a severe systemic phenotype, which included myalgia, peripheral edema and significant…

In the Journals

Baseline shoulder ultrasonography did not predict glucocorticoid response in patients with polymyalgia

February 2, 2017
Baseline shoulder ultrasonography was not predictive of glucocorticoid response in patients with polymyalgia rheumatica after 12 months, according to…

In the Journals

Population-based study: Low annual incidence of mixed connective tissue disease

December 8, 2016
Based on a cohort in Minnesota from 1985 through 2014, researchers found the yearly occurrence of mixed connective tissue disease to be two people…

In the Journals

New questionnaire more accurately identified rheumatic disease

November 8, 2016
Researchers from the University of Toronto developed a new questionnaire to more accurately screen for rheumatic disease in the outpatient setting…

In the JournalsPerspective

Consensus treatment plans developed for juvenile dermatomyositis with persistent rash

November 7, 2016
The Childhood Arthritis and Rheumatology Research Alliance developed the following three treatment plans for patients with juvenile dermatomyositis…

In the Journals

Group develops recommendations for treatment of juvenile dermatomyositis

August 15, 2016
A panel of 19 pediatric rheumatologists and two exercise physiology and physical therapy professionals involved in a European initiative called the…

Meeting News Coverage

Patients with clinically amyopathic dermatomyositis, malignancy represent unique patient subset

March 7, 2016
A higher risk for malignancy was found in patients with clinically amyopathic dermatomyositis compared to other patients with dermatomyositis, most…

In the Journals

Myositis antibodies, clinical features may predict disease course in juvenile patients

February 26, 2016
Myositis autoantibodies, particularly anti-p155/140, certain clinical features and environmental exposures were associated with a chronic disease…

In the Journals

Visfatin levels linked to disease activity in certain patients with myositis

February 12, 2016
Patients with myositis who had positive anti-Jo-1 antibody status had higher serum levels of visfatin linked to higher clinical muscle involvement…

Meeting News Coverage

Myositis patients with anti-jo-1 antibodies may have more severe muscle and lung symptoms

January 7, 2016
Patients with myositis who tested positive for anti-Jo-1 antibodies had more severe muscle and lung involvement compared to patients with anti-PM-Scl…

More Headlines »
Advertisement
Advertisement